NCT07457918 2026-03-09
COVE-4
Verrica Pharmaceuticals Inc.
Phase 3 Not yet recruiting
Clinical Trials
45 trialsNCT07246590 2026-01-21
COVE-2
Verrica Pharmaceuticals Inc.
Phase 3 Recruiting
NCT06958237 2025-09-08
Salicylic Acid Wart Patch for the Treatment of Common Warts and Plantar Warts
Langsteiner sp. z o.o.
Phase NA Completed
NCT05889845 2025-09-05
Candin for the Treatment of Common Warts
Nielsen BioSciences, Inc.
Phase 3 Completed
NCT05799157 2025-05-08
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
Veradermics, Inc.
Phase 2 Completed
NCT00472459 2025-04-18
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer
Galderma R&D
Phase 3 Completed
NCT06214559 2025-03-05
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
Swiss Footcare Laboratories - Poderm Professional
Phase NA Completed
NCT03487549 2024-11-27
COVE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT03981822 2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2 Completed
NCT03977753 2024-10-30
EVAsION
Labo'Life
Phase 4 Recruiting
NCT05896215 2024-09-27
OM202JP Clinical Study of KNP2002
KinoPharma Inc.
Phase 2 Completed
NCT05371834 2024-05-21
Microwave Treatment of Common and Plantar Warts
Blackwell Device Consulting
Phase NA Active not recruiting
NCT05877313 2024-04-17
Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)
Sanotize Research and Development corp.
Phase 2 Completed
NCT06309420 2024-03-13
Clinical Trial to Evaluate Efficacy and Safety of a Cryogenic Medical Device for Treatment of Common and Plantar Warts
Oystershell NV
Phase NA Completed
NCT04738734 2023-11-24
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
Pulse Biosciences, Inc.
Phase NA Completed
NCT01796795 2023-09-14
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
G&E Herbal Biotechnology Co., LTD
Phase 2 Suspended
NCT04554394 2023-07-27
CellFX System for the Treatment of Cutaneous Non-Genital Warts
Pulse Biosciences, Inc.
Phase NA Completed
NCT05115669 2023-02-21
Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts
Karo Pharma AB
Phase NA Completed
NCT02759900 2022-04-12
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
The Skin Center Dermatology Group
Phase NA Unknown
NCT00761371 2022-02-07
Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients
Viatris Inc.
Phase 4 Completed
NCT04253912 2021-04-01
Topical 2% Povidone-Iodine Gel in Verruca Vulgaris
Veloce BioPharma LLC
Phase 2 Unknown
NCT01757392 2021-02-04
Candin Safety & Efficacy Study for the Treatment of Warts
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT03812510 2020-11-23
Safety Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03691831 2020-10-27
A Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT03687372 2020-10-05
Study of A-101 Topical Solution for the Treatment of Common Warts
Aclaris Therapeutics, Inc.
Phase 3 Completed
NCT02393417 2019-06-04
Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Nielsen BioSciences, Inc.
Phase 2 Completed
NCT01286441 2019-05-29
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts
ViroXis Corporation
Phase 2 Completed
NCT03210337 2019-05-01
A Phase2 of A-101 Topical Solution in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT03278028 2019-04-09
A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02669862 2018-12-07
A Study of A-101 Solution in Subjects With Common Warts.
Aclaris Therapeutics, Inc.
Phase 2 Completed
NCT02640820 2018-02-23
Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyproneâ„¢) on the Clearance of Verruca Vulgaris (Common Warts)
RXi Pharmaceuticals, Corp.
Phase 2 Unknown
NCT01536834 2017-10-11
Safety & Performance Study of Verruca Treatment Device
Reckitt Benckiser LLC
Phase NA Completed
NCT03129373 2017-09-19
Clinical Study : Efficacy and Safety of Three Cryotherapy Devices for Wart Treatment
Oystershell NV
Phase NA Completed
NCT02798419 2016-08-16
Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts
Dr. Reddys Laboratories, SA
Phase 2 Completed
NCT02483455 2016-03-09
ALC-919 For The Treatment Of Common Warts
Veloce BioPharma LLC
Phase 2 Completed
NCT00546611 2016-01-28
The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)
Peplin
Phase 1 Withdrawn
NCT01555112 2013-08-15
Safety and Efficacy Study to Test Topical AS101 for External Genital Warts
BioMAS Ltd
Phase 1/2 Completed
NCT00454181 2011-09-16
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase 2 Completed
NCT00644579 2008-03-27
bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients
NatImmune A/S
Phase 2 Unknown
NCT00114920 2007-02-19
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00115141 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116662 2007-02-19
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00116675 2007-02-19
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00117871 2007-02-19
Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed
NCT00117923 2007-02-19
Study With a Topical Gel to Treat Common Warts in Adults
Graceway Pharmaceuticals, LLC
Phase 2 Completed